Glass House BrandsGLASF
Recorded

Glass House Brands 2026 Q3 Earnings Call

Review the key takeaways and the transcript of this earnings call.

PeriodQ3 2026Duration53 minParticipants6

Transcript

Preview the first fifteen paragraphs, organized by speaker.

Operator

Good afternoon, ladies and gentlemen. Welcome to the Glass House Brands Third Quarter 2026 Earnings Call. Matters discussed during today's conference call may constitute forward-looking statements that are subject to risks and uncertainties relating to Glass House Brands' future financial or business performance. Actual results could differ materially from those anticipated in those forward-looking statements. The risk factors that may affect results are detailed in Glass House Brands' periodic filings and registration statement. I would also like to remind everyone that this call is being recorded today, Monday, November 16, 2026. On today's call, we have Kyle Kazan, co-founder, Chairman, and Chief Executive Officer, and Mark Vendetti, Chief Financial Officer. Also joining for questions is Graham Farrar, co-founder and President. With that, I will turn the call over to Kyle Kazan.

Kyle KazanCo-Founder, Chairman, and CEO

Please go ahead. Thank you, operator.

Kyle KazanCo-Founder, Chairman, and CEO

First, I will be discussing Glass House Brands' recent financial performance along with the company activities. Then our CFO, Mark Vendetti, will share the financials, after which I will wrap up before the three of us take your questions. As the co-founder, Chairman, and Chief Executive Officer since day one, I am one of the key architects of how our company was built and who we are today. Since that day, Glass House Brands was built to be a company for the future, for the day when California cannabis would be legally accessible to consumers around the country and the world. However, we have been prepared and still are to succeed completely within the confines of our state until the walls come down and we are allowed to ship across our borders.

Kyle KazanCo-Founder, Chairman, and CEO

We are well-positioned as the Golden State has the beautiful California sunshine, appellation due to generations of legacy growers who created amazing strains, and the most discerning consumers of this wonderful plant. At Glass House, we are the largest cultivator on the planet, owning 6 million square feet of greenhouses. We have not turned on our entire footprint and still have room to expand when we can sell outside of California. Even though harnessing Mother Nature is not always easy, I proudly stand by the decision today to be a greenhouse grower in California, as most cannabis grown around the country is being done in warehouses at multiples more expensive than our costs. But the road not traveled is certainly not easy, as evidenced by our recent financial performance. As most of you know, pricing in California has been challenging when compared to other markets.

Kyle KazanCo-Founder, Chairman, and CEO

As such, the average price outside of California is far higher than it is within our state. When interstate commerce becomes the reality, California pricing will improve, and consumers in higher-priced states will get relief. The net effect, we believe, will be substantially higher pricing than what we are currently seeing in California. To that end, since medicinal cannabis became Schedule III, a company priority has been to work closely at the highest levels with the California Department of Cannabis Control, or the DCC. Our consultant, Matt Murphy of Pharma Compliance Group, is working with both the DCC and the Drug Enforcement Administration to understand how we can access other markets as soon as possible. Although interstate commerce is not currently a reality, we will remain focused given its importance to Glass House and consumers everywhere.

Kyle KazanCo-Founder, Chairman, and CEO

As we look outside of California, in October, we received Good Agricultural and Collection Practice, GACP, certifications for our Casitas and Padaro farms from Perry Johnson Registrars Food Safety. These certifications confirm that the facilities meet the strict international and interstate safety and quality standards required for medical cannabis markets, and they represent a critical step towards supplying those markets, both domestically and internationally, once export is permitted. Together, the two farms comprise more than half a million square feet of advanced greenhouse cultivation, making them amongst the largest GACP-certified facilities in the U.S. Markets such as Germany, the U.K., and Switzerland require GACP-compliant operations, so these certifications expand our pathway to higher-priced medicinal markets and a meaningfully larger addressable opportunity as regulatory environment continues to evolve. Turning to our third quarter results. Third quarter revenue was $56.8 million.

Kyle KazanCo-Founder, Chairman, and CEO

We produced 319,000 pounds of biomass during the quarter, a record for the company, and ahead of the 246,000 pounds produced last quarter. Third quarter cost of production was $109 a pound compared to the $122 per pound reported in the second quarter of 2026 and $175 per pound in the first quarter. This marks more than a 37% cost reduction improvement since the first quarter. The improvement comes from continued operational efficiency enhancement as our workforce gains experience every day, and we benefit from higher production volume across a larger footprint. We remain on track to produce approximately 1 million pounds of biomass this year and exit the year with cost of production around our current level, with our long-term target of $95 per pound intact.

Kyle KazanCo-Founder, Chairman, and CEO

In the second quarter of 2026, it became clear that we were growing less flower and smalls and more trim. The trim mix issue persisted into the third quarter, and our CFO estimates it cost us in excess of $10 million. As such, our average selling price for the quarter was $151 per pound, down from $211 per pound last quarter. Let me address this decrease directly. The ASP is the combination of three main factors. The trim mix we sold, the yields we achieved on flower and smalls, and the underlying market. The largest driver this quarter was mix. We sold a higher proportion of trim, roughly 63% of pounds sold, versus the high 40s and low 50s we saw in prior periods, and well above our historical best of around 45%. Flower and smalls together made up only about 37% of sales.

Kyle KazanCo-Founder, Chairman, and CEO

In 2024, for comparison, flower alone was closer to 37% in that quarter, and our 2027 projections target a meaningfully better mix. Part of this is timing. As we finished the second quarter with higher inventory levels than expected, we sold more inventory in the third quarter from earlier production periods that were more trim-heavy. The production mix improved during the quarter, and we expect further improvement in the fourth quarter. Because of the normal lag between harvest and sale, the sales mix in any given quarter does not fully reflect the production improvements already underway. Production quality and mix better indicate where we are heading. Had we sold the mix that we actually produced during the quarter, the ASP would have been higher at today's prices at $180 a pound, about $29 higher per pound than we had achieved.

Kyle KazanCo-Founder, Chairman, and CEO

As previously stated, the market is a factor as well. Flower pricing in the second quarter of 2026 was actually slightly higher than the prior year. However, in the third quarter, that reversed, and flowers sold in the high $300s a pound this quarter versus the low $400s a year ago. California wholesale price remains compressed relative to other markets and prior years, and we do not control that. Pricing is also subject to normal seasonal variation and has been softer in the back half of the year, consistent with historical patterns. What we do control is the mix and the yields, and those are the areas where we are focused. On the production side, flower and smalls per square foot ran below 2024 levels this summer. The drivers are similar to what we talked about last quarter.

Kyle KazanCo-Founder, Chairman, and CEO

The genetics we had to plant coming out of last year's disruption, a large share of the workforce still early on the learning curve as we expanded capacity, and the temporary offline status of a cogeneration unit that limited CO2. Wetter weather in the first half also played a role. These are near-term issues, not structural ones. The important point is that we are already seeing the turn. Production mix improved during the third quarter relative to the prior quarter. Operational changes, better screening, healthier plants, improved defoliation, and day-to-day execution are showing up in the numbers. We are seeing an improvement in production mix and continued progress on cost of production. These operational gains are not yet fully reflected in the financial results given the timing of sales, but they give us confidence that the trajectory is improving.

Kyle KazanCo-Founder, Chairman, and CEO

It is also important to note that none of the larger capital investments we already have underway or have planned are yet reflected in these results. These investments are designed to further improve yields, mix, and consistency as we move through 2027 to optimize Greenhouse 5 and 6. The capital we are deploying is directed toward facility upgrades and process improvements that are intended to improve yields, mix, and to support further reductions in cost of production. We recognize that the third quarter fell short on mix and average selling price. Since last year's disruption, greater scale and the use of third-party processing have made the lag between harvest and sale less predictable than it was previously, and we are working to improve that visibility. Looking to the fourth quarter, we expect the sold mix to continue improving.

Kyle KazanCo-Founder, Chairman, and CEO

Our current forecast has flower and smalls together approaching 45% of pounds sold, up from 37% in the third quarter, even as flower pricing follows its normal seasonal decline from the high $300s into the low $300s. The blended ASP may therefore remain soft in the fourth quarter, but the underlying production quality and mix appear to be heading in the right direction. As pricing typically strengthens seasonally in the first quarter, we should see the benefit of the improved mix more clearly. During the third quarter, we also made the decision to pause our hemp operations after determining that the results did not support continued investment at this time. This action allows us to concentrate resources on our core cannabis cultivation business, where we continue to see stronger opportunities for returns. We will remain disciplined in evaluating any future hemp-related opportunities should market conditions or the economics improve.

Kyle KazanCo-Founder, Chairman, and CEO

When we were getting back on our feet during the quarter, we also turned on Greenhouse 2, which boasts 11,000 lights powered by our cogeneration facilities. Frankly, it is this greenhouse we were most excited about when we first visited the facility in October of 2018. Those lights change seasonality compared to non-light-assisted greenhouses, and we believe they would produce some of the best quality cannabis on the planet. In retrospect, while our excitement about Greenhouse 2 remains, turning on another massive greenhouse while we were continuing to train and expand a new workforce took up a lot of the team's bandwidth and focus.

Kyle KazanCo-Founder, Chairman, and CEO

Given the pre-release of our third-quarter earnings, where we announced that we had $39 million in cash in the balance sheet, which we believe is enough to get us to cash flow positive, I want to address some of the tools that we have to get us there. An amazingly gritty team. I have never been luckier to call a group of individuals my longtime teammates than I am now, and I am always amazed at how we execute even during challenging times. Our preferred equity. As we created both existing rounds internally, we were deliberate that if necessary, we could forego cash dividends and convert them to payment in kind. While we have never done this, it is a lever we can pull, which would save us almost $12 million over the course of a year. Our $50 million in corporate debt.

FULL TRANSCRIPT

Continue the full translated transcript in StockNow.

Log in to unlock every statement, the English original, and speaker-by-speaker history.

Log in for the full transcript

Other earnings calls that day

View calls from this day